Lakeway, NY -- (SBWIRE) -- 03/07/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-
Aetna Inc. (NYSE:AET) shares gained 2.47% to $49.03 after the company yesterday announced it has appointed Jeff Brown as the head of Aetna Voluntary Plans. Brown is responsible for product strategy, pricing and positioning, and overall operations for the business line. Voluntary plans provide supplemental benefits, such as critical illness or accident plans, that can be paid for through payroll deductions. These plans give consumers more flexibility to choose the coverage that meets their unique needs.
How Should Investors Trade AET After The Recent Price movement? Find out Here
Cheniere Energy, Inc. (NYSEAMEX:LNG) shares climbed 2.45% and closed at $22.13. The company last month posted fourth quarter net loss of $63.52 million, wider than the prior-year loss of $7.46 million. Adjusted loss was $18.4 million. On a per share basis, loss recorded was $0.06 versus a profit of $0.30 last year. Analysts estimated loss per share of $0.05 for the quarter. Total revenue for the quarter declined to $67.3 million from $70.82 million. Analysts were looking for revenue of $68.30 million.
Is LNG a Strong Buying Opportunity After The Recent Slump? Find out Here
TE Connectivity Ltd. (NYSE:TEL) shares increased 1.49% and closed at $41.44 in yesterday’s session. The company will begin trading ex-dividend on February 27, 2013. A cash dividend payment of $0.21 per share is scheduled to be paid on March 15, 2013. Shareholders who purchased TEL stock prior to the ex-dividend date are eligible for the cash dividend payment.
Additionally, the company, on Mar. 5, announced that it will launch its new line of NG4access value-added modules (VAMs) at the Optical Fiber Communication Conference and Exposition and the National Fiber Optic Engineers Conference (OFC / NFOEC) in Anaheim, CA.
How Should Investors Trade TEL After The Recent Price movement? Find out Here
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares jumped 2.44% and closed at $49.51. VRTX‘s stock had its “sell” rating restated by equities researchers at TheStreet in a report issued on Mar. 4.
Additionally, the company, on Mar. 4, announced that treatment with VX-787 in a Phase 2 influenza challenge study resulted in statistically significant improvements in viral and clinical measurements of infection. VX-787 is an investigational new class of medicine for the treatment of influenza and is designed to directly inhibit replication of the virus.
How Should Investors Trade VRTX After The Recent Price movement? Find out Here
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)